2026 -- S 3022 | |
======== | |
LC005923 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
| |
Introduced By: Senators Bissaillon, Murray, DiMario, and DiPalma | |
Date Introduced: March 05, 2026 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance |
2 | Policies" is hereby amended by adding thereto the following section: |
3 | 27-18-96. Access to pain management services. |
4 | (a) Every individual or group health insurance contract, plan, or policy that provides |
5 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
6 | on or after January 1, 2027, shall develop a plan to provide adequate coverage of and access to a |
7 | broad spectrum of pain management services including, but not limited to, nonopioid, nonnarcotic |
8 | medication for pain management and nonmedication pain management services that serve as |
9 | alternatives to the prescribing of opioid or narcotic drugs in accordance with guidelines developed |
10 | by the office of the health insurance commissioner. |
11 | (b)(1) Approval by health insurance commissioner. Every individual or group health |
12 | insurance carrier shall file a plan required under subsection (a) of this section with the |
13 | commissioner for approval. In its review, the commissioner shall consider the adequacy of access |
14 | to a broad spectrum of pain management services under the plan and whether any policies adopted |
15 | by the carrier may create unduly preferential coverage of and access to prescribed opioids for pain |
16 | management without consideration of other pain management services. |
17 | (2) No individual or group health insurance contract, plan, or policy that provides |
18 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
19 | on or after January 1, 2027 shall apply any utilization review, including without limitation, prior |
| |
1 | authorization or step therapy protocols, for clinically appropriate nonopioid prescription drugs |
2 | approved by the United States Food and Drug Administration for the treatment or management of |
3 | moderate to severe pain, that is more restrictive or extensive than the least restrictive or extensive |
4 | utilization review applicable to any clinically appropriate opioid or narcotic drug. |
5 | (c) Information for enrollees. Every individual or group health insurance carrier shall |
6 | distribute educational materials to network providers about a pain management access plan under |
7 | subsection (a) of this section and post information about the pain management access plan on the |
8 | carrier's publicly accessible website. |
9 | SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service |
10 | Corporations" is hereby amended by adding thereto the following section: |
11 | 27-19-88. Access to pain management services. |
12 | (a) Every individual or group health insurance contract, plan, or policy that provides |
13 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
14 | on or after January 1, 2027, shall develop a plan to provide adequate coverage of and access to a |
15 | broad spectrum of pain management services including, but not limited to, nonopioid, nonnarcotic |
16 | medication for pain management and nonmedication pain management services that serve as |
17 | alternatives to the prescribing of opioid or narcotic drugs in accordance with guidelines developed |
18 | by the office of the health insurance commissioner. |
19 | (b)(1) Approval by health insurance commissioner. Every individual or group health |
20 | insurance carrier shall file a plan required under subsection (a) of this section with the |
21 | commissioner for approval. In its review, the commissioner shall consider the adequacy of access |
22 | to a broad spectrum of pain management services under the plan and whether any policies adopted |
23 | by the carrier may create unduly preferential coverage of and access to prescribed opioids for pain |
24 | management without consideration of other pain management services. |
25 | (2) No individual or group health insurance contract, plan, or policy that provides |
26 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
27 | on or after January 1, 2027 shall apply any utilization review, including without limitation, prior |
28 | authorization or step therapy protocols, for clinically appropriate nonopioid prescription drugs |
29 | approved by the United States Food and Drug Administration for the treatment or management of |
30 | moderate to severe pain, that is more restrictive or extensive than the least restrictive or extensive |
31 | utilization review applicable to any clinically appropriate opioid or narcotic drug. |
32 | (c) Information for enrollees. Every individual or group health insurance carrier shall |
33 | distribute educational materials to network providers about a pain management access plan under |
34 | subsection (a) of this section and post information about the pain management access plan on the |
| LC005923 - Page 2 of 6 |
1 | carrier's publicly accessible website. |
2 | SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service |
3 | Corporations" is hereby amended by adding thereto the following section: |
4 | 27-20-84. Access to pain management services. |
5 | (a) Every individual or group health insurance contract, plan, or policy that provides |
6 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
7 | on or after January 1, 2027, shall develop a plan to provide adequate coverage of and access to a |
8 | broad spectrum of pain management services including, but not limited to, nonopioid, nonnarcotic |
9 | medication for pain management and nonmedication pain management services that serve as |
10 | alternatives to the prescribing of opioid or narcotic drugs in accordance with guidelines developed |
11 | by the office of the health insurance commissioner. |
12 | (b)(1) Approval by health insurance commissioner. Every individual or group health |
13 | insurance carrier shall file a plan required under subsection (a) of this section with the |
14 | commissioner for approval. In its review, the commissioner shall consider the adequacy of access |
15 | to a broad spectrum of pain management services under the plan and whether any policies adopted |
16 | by the carrier may create unduly preferential coverage of and access to prescribed opioids for pain |
17 | management without consideration of other pain management services. |
18 | (2) No individual or group health insurance contract, plan, or policy that provides |
19 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
20 | on or after January 1, 2027 shall apply any utilization review, including without limitation, prior |
21 | authorization or step therapy protocols, for clinically appropriate nonopioid prescription drugs |
22 | approved by the United States Food and Drug Administration for the treatment or management of |
23 | moderate to severe pain, that is more restrictive or extensive than the least restrictive or extensive |
24 | utilization review applicable to any clinically appropriate opioid or narcotic drug. |
25 | (c) Information for enrollees. Every individual or group health insurance carrier shall |
26 | distribute educational materials to network providers about a pain management access plan under |
27 | subsection (a) of this section and post information about the pain management access plan on the |
28 | carrier's publicly accessible website. |
29 | SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance |
30 | Organizations" is hereby amended by adding thereto the following section: |
31 | 27-41-101. Access to pain management services. |
32 | (a) Every individual or group health insurance contract, plan, or policy that provides |
33 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
34 | on or after January 1, 2027, shall develop a plan to provide adequate coverage of and access to a |
| LC005923 - Page 3 of 6 |
1 | broad spectrum of pain management services including, but not limited to, nonopioid, nonnarcotic |
2 | medication for pain management and nonmedication pain management services that serve as |
3 | alternatives to the prescribing of opioid or narcotic drugs in accordance with guidelines developed |
4 | by the office of the health insurance commissioner. |
5 | (b)(1) Approval by health insurance commissioner. Every individual or group health |
6 | insurance carrier shall file a plan required under subsection (a) of this section with the |
7 | commissioner for approval. In its review, the commissioner shall consider the adequacy of access |
8 | to a broad spectrum of pain management services under the plan and whether any policies adopted |
9 | by the carrier may create unduly preferential coverage of and access to prescribed opioids for pain |
10 | management without consideration of other pain management services. |
11 | (2) No individual or group health insurance contract, plan, or policy that provides |
12 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
13 | on or after January 1, 2027 shall apply any utilization review, including without limitation, prior |
14 | authorization or step therapy protocols, for clinically appropriate nonopioid prescription drugs |
15 | approved by the United States Food and Drug Administration for the treatment or management of |
16 | moderate to severe pain, that is more restrictive or extensive than the least restrictive or extensive |
17 | utilization review applicable to any clinically appropriate opioid or narcotic drug. |
18 | (c) Information for enrollees. Every individual or group health insurance carrier shall |
19 | distribute educational materials to network providers about a pain management access plan under |
20 | subsection (a) of this section and post information about the pain management access plan on the |
21 | carrier's publicly accessible website. |
22 | SECTION 5. Chapter 40-21 of the General Laws entitled "Medical Assistance — |
23 | Prescription Drugs" is hereby amended by adding thereto the following section: |
24 | 40-21-4. Access to nonopioid pain treatment. |
25 | (a) The Rhode Island medical assistance program, as defined under chapter 8 of this title, |
26 | and any contract between the Rhode Island medical assistance program and a managed care |
27 | organization, shall not apply any utilization review, including without limitation prior authorization |
28 | or step therapy protocols, for clinically appropriate nonopioid prescription drugs approved by the |
29 | United States Food and Drug Administration for the treatment or management of moderate to |
30 | severe pain, that is more restrictive or extensive than the least restrictive or extensive utilization |
31 | review applicable to any clinically appropriate opioid or narcotic drug. |
32 | (b) The Rhode Island medical assistance program shall require, through amending current |
33 | and future medical assistance managed care contracts, that managed care organizations meet the |
34 | provisions of this section. |
| LC005923 - Page 4 of 6 |
1 | (c) This section applies to all policies, contracts, and plans executed, delivered, issued for |
2 | delivery, continued or renewed in this state on or after January 1, 2027. |
3 | SECTION 6. This act shall take effect upon passage. |
======== | |
LC005923 | |
======== | |
| LC005923 - Page 5 of 6 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
*** | |
1 | This act would require insurers to develop plans for coverage and access to nonnarcotic, |
2 | nonopioid and nonmedication pain management for moderate to severe pain. This act would further |
3 | restrict utilization review for nonopioid drugs. |
4 | This act would take effect upon passage. |
======== | |
LC005923 | |
======== | |
| LC005923 - Page 6 of 6 |